Kilitch Drugs (India) Ltd

Kilitch Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kilitch Drugs (India) Ltd

₹ 380 0.66%
07 Nov - close price
kilitch.com BSE: 524500 NSE: KILITCH
About

Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products[1]

Key Points

Business Overview:[1]
KDL is a pharmaceutical company engaged in developing, manufacturing, marketing, and exporting various Pharmaceutical Formulations in dosage forms like Solid, Liquid, and Parental.

Website BSE NSE
  • Market Cap ₹ 663 Cr.
  • Current Price ₹ 380
  • High / Low ₹ 500 / 265
  • Stock P/E 20.8
  • Book Value ₹ 145
  • Dividend Yield 0.00 %
  • ROCE 13.2 %
  • ROE 11.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 55.2% CAGR over last 5 years
  • Company's median sales growth is 15.1% of last 10 years

Cons

  • Stock is trading at 2.63 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -5.46%
  • Company has a low return on equity of 9.10% over last 3 years.
  • Earnings include an other income of Rs.14.0 Cr.
  • Company has high debtors of 168 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
23.57 22.43 28.50 43.28 31.12 31.57 29.77 39.14 33.42 45.35 46.51 56.30 34.12
20.44 19.28 24.28 36.59 25.88 25.73 25.76 33.93 30.20 39.76 38.40 42.39 30.55
Operating Profit 3.13 3.15 4.22 6.69 5.24 5.84 4.01 5.21 3.22 5.59 8.11 13.91 3.57
OPM % 13.28% 14.04% 14.81% 15.46% 16.84% 18.50% 13.47% 13.31% 9.63% 12.33% 17.44% 24.71% 10.46%
1.39 0.66 1.11 1.43 0.98 0.92 3.40 0.90 3.21 5.81 2.37 2.32 3.50
Interest 0.07 0.23 0.28 0.41 0.38 0.55 0.53 0.44 0.49 0.42 0.49 0.72 0.59
Depreciation 0.27 0.31 0.38 0.37 0.26 0.28 0.30 0.41 0.35 0.40 0.47 0.51 0.50
Profit before tax 4.18 3.27 4.67 7.34 5.58 5.93 6.58 5.26 5.59 10.58 9.52 15.00 5.98
Tax % 27.75% -11.93% 16.06% 30.11% 25.09% 28.50% 16.41% 30.80% 27.55% 16.35% 27.73% 24.20% 19.90%
3.01 3.64 3.93 5.13 4.19 4.24 5.50 3.64 4.05 8.85 6.88 11.37 4.79
EPS in Rs 1.78 2.15 2.33 3.04 2.48 2.42 3.14 2.08 2.31 5.06 3.93 6.50 2.74
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
15 19 21 27 50 96 61 70 105 118 132 182 182
19 21 24 27 44 79 59 65 94 100 111 150 151
Operating Profit -4 -2 -3 -0 6 17 2 5 11 17 20 31 31
OPM % -25% -9% -15% -0% 12% 18% 3% 8% 11% 15% 16% 17% 17%
6 3 2 1 3 4 6 4 5 5 6 14 14
Interest 0 0 0 0 0 1 1 1 1 1 2 2 2
Depreciation 1 2 2 1 1 1 1 1 1 1 1 2 2
Profit before tax 1 -1 -2 -0 7 20 5 8 14 19 23 41 41
Tax % -10% -79% -18% -91% 13% 24% 15% 18% 24% 19% 25% 23%
1 -0 -2 -0 6 15 4 6 11 16 18 31 32
EPS in Rs 0.82 -0.13 -1.42 -0.03 4.16 8.84 2.65 3.67 6.23 9.30 10.04 17.81 18.23
Dividend Payout % 0% 0% 0% 0% 11% 5% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 25%
5 Years: 24%
3 Years: 20%
TTM: 36%
Compounded Profit Growth
10 Years: 46%
5 Years: 55%
3 Years: 40%
TTM: 83%
Stock Price CAGR
10 Years: 26%
5 Years: 33%
3 Years: 31%
1 Year: 27%
Return on Equity
10 Years: 6%
5 Years: 8%
3 Years: 9%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 13 13 13 13 14 15 15 15 16 16 16 16
Reserves 107 107 105 106 117 136 136 147 162 180 207 237
0 0 0 1 1 9 13 15 20 22 31 49
9 7 8 10 13 12 10 18 34 35 33 56
Total Liabilities 129 127 126 130 145 172 174 196 232 252 287 358
9 9 8 8 7 8 8 7 14 15 16 20
CWIP 0 0 0 0 0 0 0 0 0 1 6 47
Investments 40 72 92 96 101 100 98 106 117 110 121 121
79 46 25 26 37 65 68 82 101 126 145 170
Total Assets 129 127 126 130 145 172 174 196 232 252 287 358

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-31 -8 18 1 -1 7 7 6 5 6 -3 15
72 -31 -20 -1 -2 -22 -10 -5 -16 6 -9 -41
-0 -0 -0 -0 6 15 1 2 8 3 11 16
Net Cash Flow 41 -39 -2 -0 2 0 -1 3 -3 15 0 -11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 213 243 285 200 150 88 102 120 144 165 171 168
Inventory Days 162 124 110 84 39 33 57 34 30 13 22 61
Days Payable 292 123 152 183 108 38 81 127 168 180 144 188
Cash Conversion Cycle 83 244 243 101 82 83 78 27 6 -3 49 40
Working Capital Days 102 196 230 122 98 42 20 -15 -21 4 25 57
ROCE % -2% -1% -2% -0% 5% 12% 3% 4% 7% 9% 10% 13%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
68.24% 68.24% 68.24% 69.23% 69.23% 69.23% 69.23% 69.23% 69.23% 69.23% 69.23% 63.77%
31.75% 31.75% 31.76% 30.78% 30.76% 30.77% 30.77% 30.77% 30.76% 30.77% 30.77% 36.22%
No. of Shareholders 9,4359,5229,5739,0029,0629,5259,6209,92010,1399,74910,37910,929

Documents

Announcements

Annual reports

Right Issue

Concalls